GL Ventures Completes $24 Million Series B-2 Investment in Clover Biopharmaceuticals
June 07, 2020 09:00 PM Eastern Daylight Time BEIJING–(BUSINESS WIRE)–Clover Biopharmaceuticals, a global clinical-stage biotechnology company focused on developing novel and transformative biologic therapies, today announced the completion of a US$ 24 million Series B-2 financing from GL Ventures. This financing round brings Clover’s total capital raised since… Read More